
Sign up to save your podcasts
Or
Send us a text
Welcome to our Season 10 opening episode! Today we’re discussing some of the big updates in metastatic breast cancer research from the 2024 San Antonio Breast Cancer Symposium (SABCS). Joining us today is Dr. Debu Tripathy, breast oncologist at The University of Texas MD Anderson Cancer Center who will break down into understandable terms some of the most impactful findings shared at SABCS, from advances in endocrine therapy and HER2-targeted treatments to exciting developments in PI3K inhibition and nausea control.
5
5858 ratings
Send us a text
Welcome to our Season 10 opening episode! Today we’re discussing some of the big updates in metastatic breast cancer research from the 2024 San Antonio Breast Cancer Symposium (SABCS). Joining us today is Dr. Debu Tripathy, breast oncologist at The University of Texas MD Anderson Cancer Center who will break down into understandable terms some of the most impactful findings shared at SABCS, from advances in endocrine therapy and HER2-targeted treatments to exciting developments in PI3K inhibition and nausea control.
38,618 Listeners
90,409 Listeners
27,256 Listeners
78,125 Listeners
47 Listeners
43,880 Listeners
9,320 Listeners
12,625 Listeners
111,160 Listeners
55,977 Listeners
11,871 Listeners
5,678 Listeners
5,312 Listeners
15,510 Listeners
53 Listeners